Counterfeiters threaten $1 billion pipeline of medicine
Counterfeit copies of a major pharmaceutical brand were discovered in the US market with no security measures in place to allow patients or inspectors to easily identify counterfeit goods. How did they react?
As a brand owner, can you relate to the challenge of quickly authenticating product before a dangerous situation impacts your customers? That’s what one brand owner faced when counterfeit copies of a major pharmaceutical brand were discovered in the U.S. market.
Read this case study to learn more about how one company reacted when there were no security measures in place to allow patients, healthcare professionals and law enforcement agencies to readily distinguish authentic from counterfeit medicines. With quick thinking and the right Authentix solutions in place, both patient welfare and the manufacturer’s reputation were protected.
Download the Case Study